This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Madden, K. P. Articles by Zivin, J. A. Search for Related Content PubMed PubMed Citation Articles by Madden, K. P. Articles by Zivin, J. A.

Stroke, Vol 24, 1068-1071, Copyright © 1993 by American Heart Association

ARTICLES

Delayed therapy of experimental ischemia with competitive N-methyl-D- aspartate antagonists in rabbits

KP Madden, WM Clark and JA Zivin
Department of Neurology, Marshfield Clinic, WI 54449.

BACKGROUND AND PURPOSE: N-methyl-D-aspartate antagonists are effective in limiting ischemic damage to the brain and spinal cord if treatment is begun at time of ischemic injury. More clinically relevant delayed therapy has not been adequately investigated. We report the temporal profile of efficacy for two competitive N-methyl-D-aspartate antagonists in therapy of central nervous system ischemia. METHODS: CGS- 19755 (30 mg/kg) or LY233053 (100 mg/kg) was administered 5, 30, or 60 minutes after reversible spinal cord ischemia in rabbits, induced by temporary occlusion of the infrarenal aorta. Duration of occlusion for individual animals was varied to provide a range of ischemia for each experimental group. The P50 represents the duration (in minutes) associated with a 50% probability of resultant permanent paraplegia. Neuroprotection is demonstrated if a drug prolongs the P50. RESULTS: CGS-19755 significantly prolonged the P50 (t test, P = .003) when given 5 minutes after ischemia, but not if delayed by 30 or 60 minutes (P50: control, 24.1; 5 minutes, 31.4; 30 minutes, 30.1; 60 minutes, 26.6). LY233053 was efficacious at 5 (P = .0008) and 30 (P = .002) minutes, but not at 60 minutes (P50: control, 26.8; 5 minutes, 39.4; 30 minutes, 36.0; 60 minutes, 25.6). CONCLUSIONS: These competitive N-methyl-D- aspartate antagonists are effective in limiting ischemic damage, but protection is lost if therapy is not initiated within 60 minutes of injury.

This article has been cited by other articles:

				P. de Haan, I. Vanicky, M. J. H. M. Jacobs, O. Bakker, J. Lips, S. A.G. Meylaerts, and C. J. Kalkman Effect of ischemic pretreatment on heat shock protein 72, neurologic outcome, and histopathologic outcome in a rabbit model of spinal cord ischemia J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 513 - 519. [Abstract] [Full Text] [PDF]

				G. K. Kanellopoulos, X. M. Xu, C. Y. Hsu, X. Lu, T. M. Sundt, N. T. Kouchoukos, and P. H. Chan White Matter Injury in Spinal Cord Ischemia : Protection by AMPA/Kainate Glutamate Receptor Antagonism Editorial Comment: Protection by AMPA/Kainate Glutamate Receptor Antagonism Stroke, August 1, 2000; 31(8): 1945 - 1952. [Abstract] [Full Text] [PDF]

				W.-R. Schabitz, F. Li, M. Fisher, and P. H. Chan The N-Methyl-D-Aspartate Antagonist CNS 1102 Protects Cerebral Gray and White Matter From Ischemic Injury Following Temporary Focal Ischemia in Rats Editorial Comment Stroke, July 1, 2000; 31(7): 1709 - 1714. [Abstract] [Full Text] [PDF]

				J. J. Gangemi, J. A. Kern, S. D. Ross, K. S. Shockey, I. L. Kron, and C. G. Tribble Retrograde perfusion with a sodium channel antagonist provides ischemic spinal cord protection Ann. Thorac. Surg., June 1, 2000; 69(6): 1744 - 1748. [Abstract] [Full Text] [PDF]

				S. M. Davis, K. R. Lees, G. W. Albers, H. C. Diener, S. Markabi, G. Karlsson, and J. Norris Selfotel in Acute Ischemic Stroke : Possible Neurotoxic Effects of an NMDA Antagonist Stroke, February 1, 2000; 31(2): 347 - 354. [Abstract] [Full Text] [PDF]

				F. M. Follis, K. S. Blisard, P. S. Varvitsiotis, S. B. Pett Jr, R. T. Temes, and J. A. Wernly Selective protection of gray and white matter during spinal cord ischemic injury Ann. Thorac. Surg., May 1, 1999; 67(5): 1362 - 1369. [Abstract] [Full Text] [PDF]

				H. Wakamatsu, M. Matsumoto, K. Nakakimura, and T. Sakabe The Effects of Moderate Hypothermia and Intrathecal Tetracaine on Glutamate Concentrations of Intrathecal Dialysate and Neurologic and Histopathologic Outcome in Transient Spinal Cord Ischemia in Rabbits Anesth. Analg., January 1, 1999; 88(1): 56 - 62. [Abstract] [Full Text] [PDF]

				J. Castillo, F. Martinez, E. Corredera, J.M. Aldrey, and M. Noya Amino Acid Transmitters in Patients With Headache During the Acute Phase of Cerebrovascular Ischemic Disease Stroke, November 1, 1995; 26(11): 2035 - 2039. [Abstract] [Full Text]

				J. Grotta, W. Clark, B. Coull, L. C. Pettigrew, B. Mackay, L. B. Goldstein, I. Meissner, D. Murphy, and L. LaRue Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic Stroke : Results of a Phase IIa Randomized Trial Stroke, April 1, 1995; 26(4): 602 - 605. [Abstract] [Full Text]